You just read:

Landmark TAILORx Results Aid in Assessing the Effect of Chemotherapy in Women with Early-stage Breast Cancer and Oncotype DX Breast Recurrence Score® Results of 11 to 25

News provided by

Genomic Health, Inc.

Mar 15, 2018, 08:00 ET